BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20106966)

  • 1. cAMP-stimulated protein phosphatase 2A activity associated with muscle A kinase-anchoring protein (mAKAP) signaling complexes inhibits the phosphorylation and activity of the cAMP-specific phosphodiesterase PDE4D3.
    Dodge-Kafka KL; Bauman A; Mayer N; Henson E; Heredia L; Ahn J; McAvoy T; Nairn AC; Kapiloff MS
    J Biol Chem; 2010 Apr; 285(15):11078-86. PubMed ID: 20106966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56delta subunit.
    Ahn JH; McAvoy T; Rakhilin SV; Nishi A; Greengard P; Nairn AC
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2979-84. PubMed ID: 17301223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AKAP79, PKC, PKA and PDE4 participate in a Gq-linked muscarinic receptor and adenylate cyclase 2 cAMP signalling complex.
    Shen JX; Cooper DM
    Biochem J; 2013 Oct; 455(1):47-56. PubMed ID: 23889134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes.
    Bauman AL; Soughayer J; Nguyen BT; Willoughby D; Carnegie GK; Wong W; Hoshi N; Langeberg LK; Cooper DM; Dessauer CW; Scott JD
    Mol Cell; 2006 Sep; 23(6):925-31. PubMed ID: 16973443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of protein phosphatases PP2A and PP2B to the C-terminus of the L-type calcium channel Ca v1.2.
    Xu H; Ginsburg KS; Hall DD; Zimmermann M; Stein IS; Zhang M; Tandan S; Hill JA; Horne MC; Bers D; Hell JW
    Biochemistry; 2010 Dec; 49(48):10298-307. PubMed ID: 21053940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PP2A inactivation is a crucial step in triggering apoptin-induced tumor-selective cell killing.
    Zimmerman R; Peng DJ; Lanz H; Zhang YH; Danen-Van Oorschot A; Qu S; Backendorf C; Noteborn M
    Cell Death Dis; 2012 Apr; 3(4):e291. PubMed ID: 22476099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sub-picomolar relaxin signalling by a pre-assembled RXFP1, AKAP79, AC2, beta-arrestin 2, PDE4D3 complex.
    Halls ML; Cooper DM
    EMBO J; 2010 Aug; 29(16):2772-87. PubMed ID: 20664520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatins contain a noncanonical coiled coil that binds protein phosphatase 2A A subunit to form a 2:2 heterotetrameric core of striatin-interacting phosphatase and kinase (STRIPAK) complex.
    Chen C; Shi Z; Zhang W; Chen M; He F; Zhang Z; Wang Y; Feng M; Wang W; Zhao Y; Brown JH; Jiao S; Zhou Z
    J Biol Chem; 2014 Apr; 289(14):9651-61. PubMed ID: 24550388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms underlying cardiac protein phosphatase 2A regulation in heart.
    DeGrande ST; Little SC; Nixon DJ; Wright P; Snyder J; Dun W; Murphy N; Kilic A; Higgins R; Binkley PF; Boyden PA; Carnes CA; Anderson ME; Hund TJ; Mohler PJ
    J Biol Chem; 2013 Jan; 288(2):1032-46. PubMed ID: 23204520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.
    Sangodkar J; Farrington CC; McClinch K; Galsky MD; Kastrinsky DB; Narla G
    FEBS J; 2016 Mar; 283(6):1004-24. PubMed ID: 26507691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease mutations and phosphorylation alter the allosteric pathways involved in autoinhibition of protein phosphatase 2A.
    Konovalov KA; Wu CG; Qiu Y; Balakrishnan VK; Parihar PS; O'Connor MS; Xing Y; Huang X
    J Chem Phys; 2023 Jun; 158(21):. PubMed ID: 37260014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To be or not to be: PP2A as a dual player in CNS functions, its role in neurodegeneration, and its interaction with brain insulin signaling.
    Javadpour P; Dargahi L; Ahmadiani A; Ghasemi R
    Cell Mol Life Sci; 2019 Jun; 76(12):2277-2297. PubMed ID: 30874837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended regulation interface coupled to the allosteric network and disease mutations in the PP2A-B56δ holoenzyme.
    Wu CG; Balakrishnan VK; Parihar PS; Konovolov K; Chen YC; Merrill RA; Wei H; Carragher B; Sundaresan R; Cui Q; Wadzinski BE; Swingle MR; Musiyenko A; Honkanen R; Chung WK; Suzuki A; Strack S; Huang X; Xing Y
    bioRxiv; 2023 Apr; ():. PubMed ID: 37066309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of the compartmentalized PKA substrate TAF15 regulates RNA-protein interactions.
    Feichtner A; Enzler F; Kugler V; Hoppe K; Mair S; Kremser L; Lindner H; Huber RG; Stelzl U; Stefan E; Torres-Quesada O
    Cell Mol Life Sci; 2024 Apr; 81(1):162. PubMed ID: 38568213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective BVES-mediated feedback control of cAMP in muscular dystrophy.
    Li H; Wang P; Zhang C; Zuo Y; Zhou Y; Han R
    Nat Commun; 2023 Mar; 14(1):1785. PubMed ID: 36997581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PP2A-like phosphatase Ppg1 mediates assembly of the Far complex to balance gluconeogenic outputs and enables adaptation to glucose depletion.
    Niphadkar S; Karinje L; Laxman S
    PLoS Genet; 2024 Mar; 20(3):e1011202. PubMed ID: 38452140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Phosphoprotein Activity by Phosphorylation Targeting Chimeras (PhosTACs).
    Chen PH; Hu Z; An E; Okeke I; Zheng S; Luo X; Gong A; Jaime-Figueroa S; Crews CM
    ACS Chem Biol; 2021 Dec; 16(12):2808-2815. PubMed ID: 34780684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Different Na
    Xu Y; Song X; Wang Z; Bai Y; Ren C; Hou C; Li X; Zhang D
    Foods; 2024 May; 13(11):. PubMed ID: 38890876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase A and phosphodiesterase-4D3 binding to coding polymorphisms of cardiac muscle anchoring protein (mAKAP).
    Rababa'h A; Craft JW; Wijaya CS; Atrooz F; Fan Q; Singh S; Guillory AN; Katsonis P; Lichtarge O; McConnell BK
    J Mol Biol; 2013 Sep; 425(18):3277-88. PubMed ID: 23806656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein phosphatase 2A anchoring disruptor gene therapy for familial dilated cardiomyopathy.
    Li X; Li J; Samuelsson AM; Thakur H; Kapiloff MS
    Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101233. PubMed ID: 38572067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.